Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens (Q36831660)

16 August 2017

1 reference

title

Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens (English)

1 reference

16 August 2017

Jiménez M

1

1 reference

16 August 2017

Ercilla G

series ordinal

2

1 reference

16 August 2017

Martínez C

series ordinal

3

1 reference

16 August 2017

language of work or name

1 reference

24 May 2007

1 reference

16 August 2017

1 reference

16 August 2017

21

1 reference

16 August 2017

8

1 reference

16 August 2017

1628-1637

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404681

16 August 2017

0 references

cites work

Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Changes in thymic function with age and during the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Deletion of the human T-cell receptor δ-gene by a site-specific recombination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

The structure, rearrangement and expression of Dβ gene segments of the murine T-cell antigen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Thymic aging and T-cell regeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Immune Reconstitution and Early Infectious Complications Following Nonmyeloablative Hematopoietic Stem Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Nonmyeloablative conditioning allows for more rapid T-cell repertoire reconstitution following allogeneic matched unrelated bone marrow transplantation compared to myeloablative approaches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Early reconstitution of the T-cell repertoire after non-myeloablative peripheral blood stem cell transplantation is from post-thymic T-cell expansion and is unaffected by graft-versus-host disease or mixed chimaerism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated don

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Transplantation of thymus tissue in complete DiGeorge syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: the importance of overcoming intrathymic alloresistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Characterization of human blood dendritic cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Dendritic cell-mediated T cell polarization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Phenotype, function and chimaerism of monocyte‐derived blood dendritic cells after allogeneic haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

T cell functional defect associated with thymid epithelial cell injury induced by a graft-versus-host reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Generation of functional thymocytes in the human adult.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Direct evidence for thymic function in adult humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Changes in the human thymus during aging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naïve phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Clinical factors influencing T-cell receptor excision circle (TRECs) counts following allogeneic stem cell transplantation in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-fr

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404681

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404681

1 reference

release_5ekxlxrekjc4fjoucxb6kemt3m

16 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5ekxlxrekjc4fjoucxb6kemt3m

24 November 2022

mapped directly with Wikidata item

1 reference